Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alternative Splicing: Expanding the Landscape of Cancer Biomarkers and Therapeutics
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 23, Pages 9032
Publisher
MDPI AG
Online
2020-11-28
DOI
10.3390/ijms21239032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles and mechanisms of alternative splicing in cancer — implications for care
- (2020) Sophie C. Bonnal et al. Nature Reviews Clinical Oncology
- Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
- (2020) Dingxiao Zhang et al. Nature Communications
- Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
- (2020) Mohammad Alinoor Rahman et al. Cancers
- Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer
- (2020) Haifeng Lian et al. BMC GASTROENTEROLOGY
- Treating Disease at the RNA Level with Oligonucleotides
- (2019) Arthur A. Levin NEW ENGLAND JOURNAL OF MEDICINE
- RAC1B: A Rho GTPase with Versatile Functions in Malignant Transformation and Tumor Progression
- (2019) Catharina Melzer et al. Cells
- Splicing and cancer: Challenges and opportunities
- (2019) Patricia P. Coltri et al. Wiley Interdisciplinary Reviews-RNA
- RAC1b overexpression confers resistance to chemotherapy treatment in colorectal cancer
- (2019) Erik T Goka et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic Antisense Oligonucleotides Are Coming of Age
- (2019) C. Frank Bennett Annual Review of Medicine
- More than a messenger: Alternative splicing as a therapeutic target
- (2019) A.J. Black et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
- (2019) Polina Denichenko et al. Nature Communications
- Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
- (2019) Chengkun Yang et al. Frontiers in Oncology
- Targeting mRNA processing as an anticancer strategy
- (2019) Joana Desterro et al. NATURE REVIEWS DRUG DISCOVERY
- RNA-based therapeutics for colorectal cancer: Updates and future directions
- (2019) Jingwen Liu et al. PHARMACOLOGICAL RESEARCH
- Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
- (2018) Rita Assi et al. CANCER
- Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
- (2018) Kenichi Iwai et al. EMBO Molecular Medicine
- Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer
- (2018) Junyong Zhu et al. GYNECOLOGIC ONCOLOGY
- Targeting Splicing in Prostate Cancer
- (2018) Effrosyni Antonopoulou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Eteplirsen treatment for Duchenne muscular dystrophy
- (2018) Jay S. Charleston et al. NEUROLOGY
- Alternative splicing isoforms in health and disease
- (2018) Hyoung Kyu Kim et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Computational identification and validation of alternative splicing in ZSF1 rat RNA-seq data, a preclinical model for type 2 diabetic nephropathy
- (2018) Chi Zhang et al. Scientific Reports
- Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
- (2018) Michael Seiler et al. Cell Reports
- Systematic Analysis of Splice-Site-Creating Mutations in Cancer
- (2018) Reyka G. Jayasinghe et al. Cell Reports
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
- (2018) André Kahles et al. CANCER CELL
- Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data
- (2018) Yongfu Xiong et al. EBioMedicine
- Evidence in focus: Nusinersen use in spinal muscular atrophy
- (2018) David Michelson et al. NEUROLOGY
- Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer
- (2017) Prabhsimranjot Singh et al. Journal of Hematology & Oncology
- Selective degradation of splicing factor CAPERα by anticancer sulfonamides
- (2017) Taisuke Uehara et al. Nature Chemical Biology
- hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells
- (2017) Ilaria Passacantilli et al. NUCLEIC ACIDS RESEARCH
- Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer
- (2017) Tai-Kuang Chao et al. PLoS One
- Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
- (2017) Ting Han et al. SCIENCE
- The Relationship between Alternative Splicing and Proteomic Complexity
- (2017) Benjamin J. Blencowe TRENDS IN BIOCHEMICAL SCIENCES
- Gene isoforms as expression-based biomarkers predictive of drug response in vitro
- (2017) Zhaleh Safikhani et al. Nature Communications
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
- (2017) Annemieke Aartsma-Rus et al. Nucleic Acid Therapeutics
- High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin
- (2017) Zhi-na Wang et al. Oncotarget
- Impact of Alternative Splicing on the Human Proteome
- (2017) Yansheng Liu et al. Cell Reports
- Signaling Pathways Driving Aberrant Splicing in Cancer Cells
- (2017) Vânia Gonçalves et al. Genes
- RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells
- (2017) Márcia Faria et al. PLoS One
- Alternative splicing and cell survival: from tissue homeostasis to disease
- (2016) Maria Paola Paronetto et al. CELL DEATH AND DIFFERENTIATION
- A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1
- (2016) Dror Hollander et al. GENOME RESEARCH
- Release of SR Proteins from CLK1 by SRPK1: A Symbiotic Kinase System for Phosphorylation Control of Pre-mRNA Splicing
- (2016) Brandon E. Aubol et al. MOLECULAR CELL
- Therapeutic targeting of splicing in cancer
- (2016) Stanley Chun-Wei Lee et al. NATURE MEDICINE
- Translating RNA sequencing into clinical diagnostics: opportunities and challenges
- (2016) Sara A. Byron et al. NATURE REVIEWS GENETICS
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- Alternative splicing of S6K1 promotes non-small cell lung cancer survival
- (2016) Hong Mei et al. TUMOR BIOLOGY
- Extending the Impact of RAC1b Overexpression to Follicular Thyroid Carcinomas
- (2016) Márcia Faria et al. International Journal of Endocrinology
- Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
- (2016) Samar Alsafadi et al. Nature Communications
- Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival
- (2016) Dennis Liang Fei et al. PLoS Genetics
- Mechanisms and Regulation of Alternative Pre-mRNA Splicing
- (2015) Yeon Lee et al. Annual Review of Biochemistry
- SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
- (2015) Eunhee Kim et al. CANCER CELL
- Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer
- (2015) H. Takahashi et al. MOLECULAR CANCER THERAPEUTICS
- SRSF1-Regulated Alternative Splicing in Breast Cancer
- (2015) Olga Anczuków et al. MOLECULAR CELL
- Intron retention is a widespread mechanism of tumor-suppressor inactivation
- (2015) Hyunchul Jung et al. NATURE GENETICS
- Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
- (2015) S Calabretta et al. ONCOGENE
- Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
- (2015) A Sveen et al. ONCOGENE
- Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines
- (2015) ZHAOHUI LI et al. ONCOLOGY REPORTS
- RON alternative splicing regulation in primary ovarian cancer
- (2015) SEBASTIAN MAYER et al. ONCOLOGY REPORTS
- Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing
- (2015) Shinsuke Araki et al. PLoS One
- Disease-associated mutation inSRSF2misregulates splicing by altering RNA-binding affinities
- (2015) Jian Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome
- (2015) Vikas Madan et al. Nature Communications
- Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics
- (2015) Jie Qiao et al. Oncotarget
- Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
- (2015) Rachel B. Darman et al. Cell Reports
- Widespread intron retention diversifies most cancer transcriptomes
- (2015) Heidi Dvinge et al. Genome Medicine
- Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers
- (2015) Christopher DeBoever et al. PLoS Computational Biology
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340)
- (2015) Raoni Pais Siqueira et al. PLoS One
- PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
- (2015) Wei-Ren Liu et al. Oncotarget
- Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
- (2015) Yuanyuan Qu et al. Scientific Reports
- Identification of an Exon 4-Deletion Variant of Epidermal Growth Factor Receptor with Increased Metastasis-Promoting Capacity
- (2015) Hai Wang et al. NEOPLASIA
- Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
- (2014) M V Gammons et al. BRITISH JOURNAL OF CANCER
- Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
- (2014) Fran Supek et al. CELL
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- RAC1b overexpression correlates with poor prognosis in KRAS/BRAF WT metastatic colorectal cancer patients treated with first-line FOLFOX/XELOX chemotherapy
- (2014) Virginia Alonso-Espinaco et al. EUROPEAN JOURNAL OF CANCER
- U2AF1mutations alter splice site recognition in hematological malignancies
- (2014) Janine O. Ilagan et al. GENOME RESEARCH
- Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme
- (2014) Adam M Swartz et al. Immunotherapy
- Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
- (2014) Yujun Zhao et al. JOURNAL OF MEDICINAL CHEMISTRY
- An aberrant spliced transcript of focal adhesion kinase is exclusively expressed in human breast cancer
- (2014) Ling Yao et al. Journal of Translational Medicine
- Phosphoproteomics Screen Reveals Akt Isoform-Specific Signals Linking RNA Processing to Lung Cancer
- (2014) Ioannis Sanidas et al. MOLECULAR CELL
- Akt-ing Up on SRPK1: Oncogene or Tumor Suppressor?
- (2014) Alex Toker et al. MOLECULAR CELL
- Comparison of RNA-Seq and Microarray in Transcriptome Profiling of Activated T Cells
- (2014) Shanrong Zhao et al. PLoS One
- Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells
- (2014) V. Goncalves et al. RNA
- Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation
- (2014) Avraham Maimon et al. Cell Reports
- The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
- (2014) Feng-Yang Zong et al. PLoS Genetics
- CEACAM1 Promotes Melanoma Cell Growth through Sox-2
- (2014) Rona Ortenberg et al. NEOPLASIA
- Targeting Protein-Protein Interaction by Small Molecules
- (2013) Lingyan Jin et al. Annual Review of Pharmacology and Toxicology
- Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer
- (2013) Gong-Hua Li et al. BIOINFORMATICS
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer
- (2013) Pengnan Zhang et al. CARCINOGENESIS
- RAC1b overexpression in papillary thyroid carcinoma: a role to unravel
- (2013) Ana Luísa Silva et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- hnRNP U Enhances Caspase-9 Splicing and Is Modulated by AKT-dependent Phosphorylation of hnRNP L
- (2013) Ngoc T. Vu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RBM5, 6, and 10 Differentially Regulate NUMB Alternative Splicing to Control Cancer Cell Proliferation
- (2013) Elias G. Bechara et al. MOLECULAR CELL
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer
- (2013) SEIYA SAITO et al. ONCOLOGY REPORTS
- KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival
- (2013) R. Hatami et al. Science Translational Medicine
- Misregulation of Pre-mRNA Alternative Splicing in Cancer
- (2013) J. Zhang et al. Cancer Discovery
- RNA sequencing of cancer reveals novel splicing alterations
- (2013) Jeyanthy Eswaran et al. Scientific Reports
- Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine
- (2013) Elisabeth Drucker et al. EPMA Journal
- Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing
- (2012) Federico Pelisch et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
- (2012) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers
- (2012) Michal Cohen-Eliav et al. JOURNAL OF PATHOLOGY
- The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
- (2012) Olga Anczuków et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- S6K1 Alternative Splicing Modulates Its Oncogenic Activity and Regulates mTORC1
- (2012) Vered Ben-Hur et al. Cell Reports
- Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
- (2012) Z. Wang et al. Open Biology
- WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
- (2011) Elianna M. Amin et al. CANCER CELL
- Splicing Factor hnRNP A2/B1 Regulates Tumor Suppressor Gene Splicing and Is an Oncogenic Driver in Glioblastoma
- (2011) R. Golan-Gerstl et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Asyn-anticonformational difference allows SRSF2 to recognize guanines and cytosines equally well
- (2011) Gerrit M Daubner et al. EMBO JOURNAL
- Growth and metastasis suppression of glioma xenografts expressing exon 4-deletion variant of epidermal growth factor receptor by monoclonal antibody CH12-mediated receptor degradation
- (2011) Hai Wang et al. FASEB JOURNAL
- Increased levels of noisy splicing in cancers, but not for oncogene-derived transcripts
- (2011) Lu Chen et al. HUMAN MOLECULAR GENETICS
- Re-expression of CEACAM1 long cytoplasmic domain isoform is associated with invasion and migration of colorectal cancer
- (2011) Junji Ieda et al. INTERNATIONAL JOURNAL OF CANCER
- Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre-RNA Splicing
- (2011) Mansour Debdab et al. JOURNAL OF MEDICINAL CHEMISTRY
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
- (2011) Irina M. Shapiro et al. PLoS Genetics
- Alternative Splicing of Caspase 9 Is Modulated by the Phosphoinositide 3-Kinase/Akt Pathway via Phosphorylation of SRp30a
- (2010) J. C. Shultz et al. CANCER RESEARCH
- Turning on a Fuel Switch of Cancer: hnRNP Proteins Regulate Alternative Splicing of Pyruvate Kinase mRNA
- (2010) M. Chen et al. CANCER RESEARCH
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged
- (2010) C. J. David et al. GENES & DEVELOPMENT
- Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene
- (2010) Cristina Valacca et al. JOURNAL OF CELL BIOLOGY
- hnRNP L regulates the tumorigenic capacity of lung cancer xenografts in mice via caspase-9 pre-mRNA processing
- (2010) Rachel Wilson Goehe et al. JOURNAL OF CLINICAL INVESTIGATION
- Global Profiling and Molecular Characterization of Alternative Splicing Events Misregulated in Lung Cancer
- (2010) C. M. Misquitta-Ali et al. MOLECULAR AND CELLULAR BIOLOGY
- Exon-Level Microarray Analyses Identify Alternative Splicing Programs in Breast Cancer
- (2010) A. Lapuk et al. MOLECULAR CANCER RESEARCH
- Alternative splicing and evolution: diversification, exon definition and function
- (2010) Hadas Keren et al. NATURE REVIEWS GENETICS
- Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways
- (2009) Vânia Gonçalves et al. HUMAN MOLECULAR GENETICS
- RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant
- (2009) Carmen Eckerich et al. JOURNAL OF NEUROCHEMISTRY
- Cancer-associated regulation of alternative splicing
- (2009) Julian P Venables et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
- (2009) Haihao Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
- (2008) A H R Varey et al. BRITISH JOURNAL OF CANCER
- The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice
- (2008) E S Rennel et al. BRITISH JOURNAL OF CANCER
- A Functional Role for KLF6-SV1 in Lung Adenocarcinoma Prognosis and Chemotherapy Response
- (2008) A. DiFeo et al. CANCER RESEARCH
- Cyclin D1b Is Aberrantly Regulated in Response to Therapeutic Challenge and Promotes Resistance to Estrogen Antagonists
- (2008) Y. Wang et al. CANCER RESEARCH
- Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III
- (2008) Junya Fukai et al. CANCER SCIENCE
- Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development
- (2008) U. Sahin et al. CLINICAL CANCER RESEARCH
- Alternative Splicing and Tumor Progression
- (2008) Claudia Ghigna et al. CURRENT GENOMICS
- The emerging role of splicing factors in cancer
- (2008) Ana Rita Grosso et al. EMBO REPORTS
- Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer
- (2008) Mark Hartel et al. EUROPEAN JOURNAL OF CANCER
- B-RafV600E Cooperates With Alternative Spliced Rac1b to Sustain Colorectal Cancer Cell Survival
- (2008) Paulo Matos et al. GASTROENTEROLOGY
- Ras Promotes Growth by Alternative Splicing-Mediated Inactivation of the KLF6 Tumor Suppressor in Hepatocellular Carcinoma
- (2008) Steven Yea et al. GASTROENTEROLOGY
- Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients
- (2008) Rong Li et al. HUMAN PATHOLOGY
- Increased Rac1b Expression Sustains Colorectal Tumor Cell Survival
- (2008) P. Matos et al. MOLECULAR CANCER RESEARCH
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
- Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
- (2008) Qun Pan et al. NATURE GENETICS
- Mapping and quantifying mammalian transcriptomes by RNA-Seq
- (2008) Ali Mortazavi et al. NATURE METHODS
- RNA-Seq: a revolutionary tool for transcriptomics
- (2008) Zhong Wang et al. NATURE REVIEWS GENETICS
- Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
- (2008) Herbert Riechelmann et al. ORAL ONCOLOGY
- The -catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression
- (2008) V. Goncalves et al. RNA
- Splicing regulation: From a parts list of regulatory elements to an integrated splicing code
- (2008) Z. Wang et al. RNA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started